The weight lowering effect of sibutramine and its impact on serum lipids in cardiovascular high risk patients with and without type 2 diabetes mellitus - an analysis from the SCOUT lead-in period

Peter Weeke; Charlotte Andersson; Emil L Fosbøl; Bente Brendorp; Lars Køber; Arya M Sharma; Nick Finer; Philip James Douglass; Ian D Caterson; Richard A Rode; Christian Torp-Pedersen

doi:10.1186/1472-6823-10-3

The weight lowering effect of sibutramine and its impact on serum lipids in cardiovascular high risk patients with and without type 2 diabetes mellitus - an analysis from the SCOUT lead-in period

Peter Weeke, Charlotte Andersson, Emil L Fosbøl, Bente Brendorp, Lars Køber, Arya M Sharma, Nick Finer, Philip James Douglass, Ian D Caterson, Richard A Rode, Christian Torp-Pedersen

Medicinsk Afdeling, Glostrup AHH

18 Citationer (Scopus)

Abstract

ABSTRACT:

Originalsprog	Engelsk
Tidsskrift	B M C Endocrine Disorders
Vol/bind	10
Sider (fra-til)	3
ISSN	1472-6823
DOI	https://doi.org/10.1186/1472-6823-10-3
Status	Udgivet - 1 jan. 2010

Adgang til dokumentet

10.1186/1472-6823-10-3

Andre filer og links

Link to publication in Scopus

Citationsformater

Weeke, P., Andersson, C., Fosbøl, E. L., Brendorp, B., Køber, L., Sharma, A. M., Finer, N., Douglass, P. J., Caterson, I. D., Rode, R. A., & Torp-Pedersen, C. (2010). The weight lowering effect of sibutramine and its impact on serum lipids in cardiovascular high risk patients with and without type 2 diabetes mellitus - an analysis from the SCOUT lead-in period. B M C Endocrine Disorders, 10, 3. https://doi.org/10.1186/1472-6823-10-3

The weight lowering effect of sibutramine and its impact on serum lipids in cardiovascular high risk patients with and without type 2 diabetes mellitus - an analysis from the SCOUT lead-in period. / Weeke, Peter; Andersson, Charlotte; Fosbøl, Emil L et al.
I: B M C Endocrine Disorders, Bind 10, 01.01.2010, s. 3.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

Weeke, P, Andersson, C, Fosbøl, EL, Brendorp, B, Køber, L, Sharma, AM, Finer, N, Douglass, PJ, Caterson, ID, Rode, RA & Torp-Pedersen, C 2010, 'The weight lowering effect of sibutramine and its impact on serum lipids in cardiovascular high risk patients with and without type 2 diabetes mellitus - an analysis from the SCOUT lead-in period', B M C Endocrine Disorders, bind 10, s. 3. https://doi.org/10.1186/1472-6823-10-3

@article{8649f60e9d7f4f71aff382ffcfccfbb2,

title = "The weight lowering effect of sibutramine and its impact on serum lipids in cardiovascular high risk patients with and without type 2 diabetes mellitus - an analysis from the SCOUT lead-in period",

abstract = "ABSTRACT:",

author = "Peter Weeke and Charlotte Andersson and Fosb{\o}l, \{Emil L\} and Bente Brendorp and Lars K{\o}ber and Sharma, \{Arya M\} and Nick Finer and Douglass, \{Philip James\} and Caterson, \{Ian D\} and Rode, \{Richard A\} and Christian Torp-Pedersen",

year = "2010",

month = jan,

day = "1",

doi = "10.1186/1472-6823-10-3",

language = "English",

volume = "10",

pages = "3",

journal = "B M C Endocrine Disorders",

issn = "1472-6823",

publisher = "BioMed Central Ltd",

}

TY - JOUR

T1 - The weight lowering effect of sibutramine and its impact on serum lipids in cardiovascular high risk patients with and without type 2 diabetes mellitus - an analysis from the SCOUT lead-in period

AU - Weeke, Peter

AU - Andersson, Charlotte

AU - Fosbøl, Emil L

AU - Brendorp, Bente

AU - Køber, Lars

AU - Sharma, Arya M

AU - Finer, Nick

AU - Douglass, Philip James

AU - Caterson, Ian D

AU - Rode, Richard A

AU - Torp-Pedersen, Christian

PY - 2010/1/1

Y1 - 2010/1/1

N2 - ABSTRACT:

AB - ABSTRACT:

UR - https://www.scopus.com/pages/publications/77949384561

U2 - 10.1186/1472-6823-10-3

DO - 10.1186/1472-6823-10-3

M3 - Journal article

C2 - 20184783

SN - 1472-6823

VL - 10

SP - 3

JO - B M C Endocrine Disorders

JF - B M C Endocrine Disorders

ER -

The weight lowering effect of sibutramine and its impact on serum lipids in cardiovascular high risk patients with and without type 2 diabetes mellitus - an analysis from the SCOUT lead-in period

Abstract

Adgang til dokumentet

Andre filer og links

Fingeraftryk

Citationsformater